PCVX 250516 30.00P(PCVX250516P30000) Stock Price Today

US OptionsDetailed Quotes

PCVX250516P30000

Watchlist

0.70
+0.05+7.69%

15min DelayClose May 9 16:00 ET

0.70High0.62Low

Intraday

5D
Daily

News

Vaxcyte, Inc. Reports Q1 2025 Financial Results
TipRanksMay 9 01:25 ET
TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating, Cuts Target Price to $85
Moomoo NewsMay 8 13:31 ET · Ratings
Needham Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $90
Moomoo NewsMay 8 13:31 ET · Ratings
Vaxcyte Shares Are Trading Higher After the Company Reported Better-than-expected Q1 EPS Results.
BenzingaMay 8 10:53 ET
Optimistic Outlook for Vaxcyte's Vaccines Drives Buy Rating
TipRanksMay 7 19:05 ET · Ratings
Vaxcyte | 10-Q: Q1 2025 Earnings Report
SECMay 7 16:24 ET · Announcements

Comments

Kim10

Mar 31 21:38

$Vaxcyte (PCVX.US)$ brutal

Movers and Shakers

Mar 31 20:37

Columns Today's Pre-Market Movers and Top Ratings | TSLA, COOP, HUT and more

Morning Movers
Gapping Up
$Corcept Therapeutics (CORT.US)$ surged over 60% after the company announced that its Phase 3 trial, ROSELLA, met its primary endpoint, improving progression-free survival in platinum-resistant ovarian cancer patients.
$QuantaSing Group (QSG.US)$ surged 20.18% in pre-market trading following a 12% increase on Friday. Last week, QuantaSing Group expanded into the pop toys market through the strategic acqui...

Car tariffs and Q1 delivery shortfalls: How will Tesla perform?

Teddy123

Mar 31 19:18

Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study

$Vaxcyte (PCVX.US)$
Breakthrough: Vaxcyte's New Vaccine Shows Promise in Phase 2 Infant Trial

Trytosaveabit

Sep 3, 2024 19:29

Update

$Vaxcyte (PCVX.US)$ Vaxcyte Inc - at All Doses Studied, Vax-31 Was Observed to Be Well Tolerated and Demonstrated a Safety Profile Similar to Prevnar 20

Meltyy

May 16, 2024 14:29

🔔 Perceptive Advisors Q1 ‘24* Holdings Released... 🐳

» Holdings: 112
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
...